Absorption of drugs from non-oral extravascular routes MCQs With Answer

Absorption of drugs from non-oral extravascular routes is a vital area in pharmaceutics and pharmacokinetics for B.Pharm students. This topic covers how drugs enter systemic circulation when administered via routes such as transdermal, sublingual, buccal, nasal, pulmonary, rectal, vaginal, intramuscular, and subcutaneous. Key concepts include permeability barriers, Fick’s law, pKa and ionization, lipid solubility, blood flow, formulation factors, lymphatic uptake, local metabolism, and bioavailability. Understanding these principles helps optimize therapeutic effect and minimize adverse reactions. Mastery of route-specific factors and absorption kinetics is essential for dosage form design and clinical application. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. Which factor most directly increases transdermal drug absorption?

  • Increasing drug molecular weight
  • Enhancing skin hydration
  • Decreasing drug lipophilicity
  • Applying at a cold temperature

Correct Answer: Enhancing skin hydration

Q2. The main barrier to percutaneous absorption is:

  • Stratum corneum
  • Dermal capillaries
  • Hypodermis fat layer
  • Hair follicles

Correct Answer: Stratum corneum

Q3. Which route bypasses hepatic first-pass metabolism most effectively?

  • Oral
  • Rectal (upper rectum)
  • Sublingual
  • Gastrostomy

Correct Answer: Sublingual

Q4. For a weakly basic drug, absorption from vaginal route is favored when the vaginal pH is:

  • Much higher than pKa
  • Much lower than pKa
  • Equal to pKa
  • Irrelevant to pKa

Correct Answer: Much higher than pKa

Q5. Which statement about intramuscular (IM) injections is correct?

  • IM absorption is independent of blood flow
  • IM injections always provide slower absorption than subcutaneous
  • IM absorption can be increased by massage
  • IM route bypasses lymphatic uptake

Correct Answer: IM absorption can be increased by massage

Q6. Lymphatic uptake of drugs is most important for:

  • Very small hydrophilic molecules
  • Large lipophilic molecules and lipophilic drug-lipid complexes
  • Strong acids with low molecular weight
  • Inorganic ions

Correct Answer: Large lipophilic molecules and lipophilic drug-lipid complexes

Q7. Which formulation strategy enhances nasal absorption of peptides?

  • Increase enzymatic degradation
  • Include protease inhibitors
  • Lower residence time in nasal cavity
  • Reduce mucoadhesive properties

Correct Answer: Include protease inhibitors

Q8. The primary mechanism for drug uptake across alveolar epithelium (pulmonary route) is:

  • Active transport via carriers
  • Endocytosis only
  • Passive diffusion across the epithelial membrane
  • Filtration through tight junctions exclusively

Correct Answer: Passive diffusion across the epithelial membrane

Q9. Which factor does NOT significantly affect subcutaneous absorption?

  • Local blood flow
  • Particle size of suspension
  • Ambient temperature
  • Gastric pH

Correct Answer: Gastric pH

Q10. Buccal absorption is especially useful for drugs that:

  • Have extensive hepatic first-pass metabolism
  • Require delivery to the colon
  • Are unstable in saliva
  • Are highly ionized at buccal pH

Correct Answer: Have extensive hepatic first-pass metabolism

Q11. Which property favors passive diffusion across biological membranes?

  • High molecular weight and high polarity
  • High lipophilicity and low molecular weight
  • Strong ionization at physiological pH
  • Strictly charged molecules

Correct Answer: High lipophilicity and low molecular weight

Q12. Rectal administration can partially avoid first-pass metabolism because:

  • All rectal veins drain to hepatic portal vein
  • Lower rectal veins drain directly to systemic circulation
  • Rectal mucosa has no enzymes
  • Rectal pH completely ionizes all drugs

Correct Answer: Lower rectal veins drain directly to systemic circulation

Q13. Which enhancer mechanism increases transdermal drug delivery?

  • Strengthening hydrogen bonding in stratum corneum
  • Extracting lipids from stratum corneum to increase permeability
  • Decreasing drug solubility in the vehicle
  • Raising skin electrical resistance

Correct Answer: Extracting lipids from stratum corneum to increase permeability

Q14. Tmax after sublingual administration compared to oral administration is generally:

  • Longer due to slower absorption
  • Shorter due to rapid transmucosal uptake
  • Identical always
  • Dependent only on gastric emptying

Correct Answer: Shorter due to rapid transmucosal uptake

Q15. Which ocular route factor limits drug absorption into the anterior chamber?

  • Tear turnover and nasolacrimal drainage
  • High corneal permeability for hydrophilic drugs
  • Absence of corneal epithelium
  • Presence of a continuous capillary network in cornea

Correct Answer: Tear turnover and nasolacrimal drainage

Q16. The Henderson-Hasselbalch concept is important for extravascular absorption because it predicts:

  • Drug crystalline polymorphism
  • Fraction of drug ionized at a given pH
  • Protein binding percentage only
  • The dissolution rate in gastric fluid

Correct Answer: Fraction of drug ionized at a given pH

Q17. Depot formulations given intramuscularly prolong absorption mainly by:

  • Rapidly increasing local blood flow
  • Providing a slow-release reservoir at injection site
  • Converting drug to highly water-soluble salt
  • Immediate systemic clearance

Correct Answer: Providing a slow-release reservoir at injection site

Q18. Which nasal delivery attribute enhances systemic absorption of small molecules?

  • High mucociliary clearance rate
  • Large surface area and rich vascularization of nasal mucosa
  • Thick keratinized epithelium
  • Poor blood supply

Correct Answer: Large surface area and rich vascularization of nasal mucosa

Q19. Which statement best describes bioavailability (F) for non-oral extravascular routes?

  • F is always equal to 1 (100%) for extravascular routes
  • F can be less than 100% due to local metabolism, incomplete absorption, or binding
  • F only depends on dose volume
  • F is not influenced by formulation

Correct Answer: F can be less than 100% due to local metabolism, incomplete absorption, or binding

Q20. Which excipient is commonly used to improve transdermal drug partitioning into skin?

  • Hydrophobic polymer with low solubility
  • Oleic acid as a chemical penetration enhancer
  • Sodium chloride crystals
  • Polymers that decrease drug solubility in vehicle

Correct Answer: Oleic acid as a chemical penetration enhancer

Q21. Which route is preferred for rapid systemic effect of emergency drugs without IV access?

  • Transdermal patch
  • Intramuscular injection
  • Topical cream
  • Vaginal suppository

Correct Answer: Intramuscular injection

Q22. For inhalation therapy, particle size between 1–5 µm is ideal because it:

  • Deposits in oropharynx predominantly
  • Reaches lower respiratory tract and alveoli
  • Is exhaled without deposition
  • Causes immediate systemic toxicity

Correct Answer: Reaches lower respiratory tract and alveoli

Q23. Which condition will decrease absorption from subcutaneous depot of an insulin suspension?

  • Increased local blood flow due to heat
  • Injection into highly perfused muscle
  • Formation of a crystalline depot that slows dissolution
  • Administration of a low-viscosity solution

Correct Answer: Formation of a crystalline depot that slows dissolution

Q24. Mucoadhesive formulations for buccal or nasal delivery primarily aim to:

  • Decrease contact time with mucosa
  • Increase residence time and absorption
  • Promote rapid mucociliary clearance
  • Prevent any drug permeation

Correct Answer: Increase residence time and absorption

Q25. Which of the following increases rectal mucosal absorption of a drug?

  • Formulating as a poorly water-soluble waxy base only
  • Using a suppository base that melts at body temperature
  • Maximizing particle agglomeration
  • Minimizing contact with rectal mucosa

Correct Answer: Using a suppository base that melts at body temperature

Q26. Enzymatic degradation is a significant barrier for which non-oral route?

  • Sublingual route for small lipophilic drugs
  • Nasal and pulmonary routes for peptides and proteins
  • Transdermal for nonpolar molecules
  • Intramuscular for inorganic ions

Correct Answer: Nasal and pulmonary routes for peptides and proteins

Q27. Which parameter best describes the rate of absorption from a non-oral extravascular route?

  • Bioavailability (F)
  • Absorption rate constant (ka)
  • Elimination half-life (t1/2)
  • Volume of distribution (Vd)

Correct Answer: Absorption rate constant (ka)

Q28. Which of the following increases nasal systemic absorption of small molecules?

  • High mucociliary clearance and low residence time
  • Use of mucoadhesive polymers to prolong contact
  • Strongly basic drug ionized at nasal pH
  • Large particulate suspensions >50 µm

Correct Answer: Use of mucoadhesive polymers to prolong contact

Q29. A major advantage of transdermal delivery over oral is:

  • Increased hepatic first-pass metabolism
  • Steady plasma levels and improved patient compliance
  • High fluctuation in plasma concentration
  • Requirement for large frequent dosing

Correct Answer: Steady plasma levels and improved patient compliance

Q30. Which formulation approach can protect peptides from degradation in nasal or pulmonary delivery?

  • Co-administration with proteases
  • Encapsulation in nanoparticles or liposomes
  • Using highly aqueous, enzyme-rich vehicle
  • Reducing contact time to seconds

Correct Answer: Encapsulation in nanoparticles or liposomes

Authors

  • Pharmacy Freak Editorial Team is the official editorial voice of PharmacyFreak.com, dedicated to creating high-quality educational resources for healthcare learners. Our team publishes and reviews exam preparation content across pharmacy, nursing, coding, social work, and allied health topics, with a focus on practice questions, study guides, concept-based learning, and practical academic support. We combine subject research, structured editorial review, and clear presentation to make difficult topics more accessible, accurate, and useful for learners preparing for exams and professional growth.

  • G S Sachin Author Pharmacy Freak
    : Reviewer

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators